Health
GSK says long-acting HIV prevention drug 66% more effective than Truvada – WHTC News
(Reuters) – Britain’s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 66% more effective in preventing HIV infections than Gilead’s Truvada daily oral pills.
HIV incidence rate – or the number of people wh…
(Reuters) – Britain’s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 66% more effective in preventing HIV infections than Gilead’s Truvada daily…
-
General23 hours agoCharlie Kirk: an examined life
-
Noosa News23 hours agoBrisbane Festival’s Shakespearean hit with Taylor Swift vibes
-
Noosa News23 hours agoQueensland Police charge West End man with threatening to kill Justice for Palestine Magan-djin campaigner Remah Naji in Brisbane
-
Noosa News23 hours agoWhom did the US president accuse of ‘hurting Australia’? Take the Brisbane Times Quiz